Skip to content

Transrectal natural orifice transluminal endosaopic surgery (NOTES) for the diagnosis and treatment of renal or adrenal diseases

Transrectal natural orifice transluminal endosaopic surgery (NOTES) for the diagnosis and treatment of renal or adrenal diseases

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031422
Enrollment
Unknown
Registered
2020-03-31
Start date
2020-03-30
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal or adrenal disease

Interventions

singel arm:Transrectal Natural orifice transluminal endoscopic surgery

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with renal or adrenal diseases.

Exclusion criteria

Exclusion criteria: 1. Patients with severe multi-organ diseases who cannot tolerate endoscopy; 2. With Severe coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
operative time;complications evaluation;hospital stay;renal function;

Countries

China

Contacts

Public ContactBingrong Liu

The First Affiliated Hospital of Zhengzhou University

bingrongliu@qq.com+86 15713855559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026